Implantable cardioveter defibrillator treatment in a patient with idiopathic ventricular fibrillation showing mild ST-T variation in V1-V3 leads
暂无分享,去创建一个
Y. Aizawa | H. Fukunaga | H. Okumura | M. Chinushi | Y. Hosaka | M. Tagawa | T. Washizuka | M. Hayashi | H. Kasai | Akira Abe
[1] J. Towbin,et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.
[2] C Antzelevitch,et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.
[3] C. Antzelevitch,et al. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. , 1999, Circulation.
[4] M A Hlatky,et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). , 1998, Circulation.
[5] J. Brugada,et al. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. , 1998, Circulation.
[6] Y. Aizawa,et al. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. , 1997, Journal of electrocardiology.
[7] J. Brugada,et al. Further Characterization of the Syndrome of Right Bundle Branch Block, ST Segment Elevation, and Sudden Cardiac Death , 1997, Journal of cardiovascular electrophysiology.
[8] K. Harumi,et al. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigators. , 1996, The American journal of cardiology.
[9] Y. Aizawa,et al. Electrophysiological Findings in Idiopathic Recurrent Ventricular Fibrillation: Special Reference to Mode of Induction, Drug Testing, and Long‐Term Outcomes , 1996, Pacing and clinical electrophysiology : PACE.
[10] Y. Aizawa,et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. , 1996, Journal of the American College of Cardiology.
[11] J. Brugada,et al. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.
[12] M. Cooper,et al. Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation. , 1988, Journal of the American College of Cardiology.
[13] P. Kudenchuk,et al. Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias. , 1986, Journal of the American College of Cardiology.